1. Home
  2. ACH vs PRQR Comparison

ACH vs PRQR Comparison

Compare ACH & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACH

Accendra Health Inc.

N/A

Current Price

$3.20

Market Cap

217.5M

Sector

N/A

ML Signal

N/A

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.90

Market Cap

244.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACH
PRQR
Founded
1882
2012
Country
United States
Netherlands
Employees
6500
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
217.5M
244.1M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ACH
PRQR
Price
$3.20
$1.90
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$3.38
$7.25
AVG Volume (30 Days)
567.4K
863.6K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.43
$13.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.84
$1.33
52 Week High
$4.69
$3.10

Technical Indicators

Market Signals
Indicator
ACH
PRQR
Relative Strength Index (RSI) 41.54 58.12
Support Level $2.55 $1.37
Resistance Level $3.13 $1.99
Average True Range (ATR) 0.27 0.11
MACD -0.05 0.01
Stochastic Oscillator 16.88 70.59

Price Performance

Historical Comparison
ACH
PRQR

About ACH Accendra Health Inc.

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: